Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 23, 2015
Seom guidelines for the treatment of gastric cancer 2015M Martin-Richard, A Custodio, C García-Girón, et al.
Clinical Colorectal Cancer|November 26, 2002
Tegafur and uracil plus leucovorin in advanced colorectal cancer: a phase II trialE Aranda, A Antón-Torres, J Sastre, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 1997
Modified weekly regimen with vinorelbine as a single agent in unresectable non-small cell lung cancerA Carrato, R Rosell, C Camps, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II studyF Cardenal, M Domine, B Massutí, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 9, 2016
Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patientsMª A Vaz Salgado, M Soto, Mª E Reguero, et al.
Revista Clinica Espanola|November 1, 1994
[A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients]J L González Larriba, V Alberola, P Lianes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD)E Aranda, A Cervantes, A Carrato, et al.
Critical Reviews in Oncology/Hematology|January 1, 2010
First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)J Sastre, E Aranda, C Grávalos, et al.
European Urology|January 1, 2003
Gender-related differences in clinical and pathological characteristics and therapy of bladder cancerD Puente, N Malats, L Cecchini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Phase I/II trial of irinotecan plus high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy in advanced colorectal cancerE Aranda, A Carrato, A Cervantes, et al.
Pageof 11